Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase EARLY_PHASE1 8Phase 4 5Phase 1 5Phase NA 3Phase 3 3Phase 1/2 2Phase 2/3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Glioblastoma 1Breast Neoplasms 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × fluciclovine F-18 × Clear all
NCT03926507 2024-10-09

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

M.D. Anderson Cancer Center

Phase NA Completed
12 enrolled
CNS

Glioblastoma

NCT05035732 2024-01-18

A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)

M.D. Anderson Cancer Center

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT03036943 2018-12-19

FRONTIER

University of Oxford

Phase NA Completed
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡